Returning after a fortnight’s break from the news cycle, it struck me how there’s now overwhelming evidence the Covid-19 pandemic is over. Witness the tweet republished above from Prof Shabir Madhi, Dean of the Health Sciences faculty at Wits University. Also in the piece below from our partners at the Financial Times of London.
This comes as no surprise to our tribe, having been telegraphed in pre-Christmas interviews with the likes of Netcare CEO Dr Richard Friedland (Dec 13) and pandemic-book author Brian Pottinger (Dec 24). Similarly, it’s logical that vested interests will continue beating their drum long after dancers-to-their-tune have departed.
___STEADY_PAYWALL___
As we recently published on BizNews, vaccine maker Pfizer admits this is a “once in an epoch” windfall for the multinational. Given there’s billions still to be harvested while the official narrative continues, don’t expect armies of propagandists to leave the battlefield. So, expect Big Pharma and those it funds to continue fuelling doubt about another deadly outbreak around the corner.
For the rational mind, however, the conclusions are obvious. History tells us Covid-19 would evolve into a more transmissible but far less dangerous infection. Just like Spanish Flu more than 100 years ago. The now dominant Omicron’s mortality rate is under 10% of previous strains. The pandemic is over. Normality will return. What great news to start the new year.
More for you to read today:
- The Best Investment for This Coming Crazy Year. Stocks are soaring. The pandemic is raging. The Fed may be hiking. Here’s how to keep a steady hand amid the madness.
- New Omicron Studies Help Explain Why the Variant Is Mild but Spreads Fast. Lab studies and clinical data support early reports about the variant that is responsible for the dramatic surge in Covid-19 cases
- McKinsey’s new top executive, who spent six years in SA, wants to change how the firm operates. Bob Sternfels discusses speeding up decision making, rethinking performance evaluations and avoiding future scandals
As a Premium subscriber you are entitled to full membership of wsj.com (normal price $29 a month). Be sure to action your access through the Premium link on the BizNews website. Because of The Wall Street Journal’s credential requirements, be sure to create a password which has at least 8 characters and includes at least one letter and one number – NB it MAY NOT contain any special characters (ie #, !, @ etc). To maintain access to WSJ.com, you MUST enter our partner’s website via BizNews Premium at least once a month. A final PS, if you had previously signed up for WSJ you’ll need to clear the cookies from your device. Our help desk can assist – [email protected].